Related Experiment Video
Updated: Oct 25, 2025

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Clinical characteristics and risk stratification of desmoplakin cardiomyopathy
Weijia Wang1,2, Brittney Murray1, Crystal Tichnell1
1Division of Cardiology, Department of Medicine, Johns Hopkins University, Johns Hopkins Hospital, Blalock 545, 600 North Wolfe Street, Baltimore, MD 21287, USA.
Insights
Desmoplakin (DSP) cardiomyopathy impacts both heart ventricles, posing a high risk for ventricular arrhythmias and heart failure. Myocardial injury is linked to poorer outcomes, highlighting the need for improved diagnosis and risk assessment in DSP cardiomyopathy.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Desmoplakin (DSP) cardiomyopathy is an emerging cause of arrhythmogenic cardiomyopathy.
- Genetic variants in DSP are increasingly recognized as a cause of inherited heart disease.
Purpose of the Study:
- To characterize the diagnosis, natural history, and risk of ventricular arrhythmia and heart failure in DSP cardiomyopathy using a genotype-specific approach.
- To evaluate the prognostic value of clinical factors and diagnostic criteria in DSP cardiomyopathy.
Main Methods:
- Followed 91 individuals with pathogenic DSP variants for a median of 4.3 years.
- Assessed ventricular involvement (left, right, or biventricular predominance).
- Analyzed incidence rates of sustained ventricular arrhythmia and heart failure, and their association with clinical factors like myocardial injury and ventricular dysfunction.
Main Results:
- Left ventricular predominance was most common (28%).
- Myocardial injury occurred in 22% and was associated with increased risk of ventricular arrhythmia and heart failure.
- Low left ventricular ejection fraction (<35%) and right ventricular dysfunction predicted ventricular arrhythmia, while proband status and myocardial injury predicted heart failure.
- The arrhythmogenic right ventricular cardiomyopathy Task Force Criteria had limited sensitivity (73%) for diagnosing left-dominant disease.
Conclusions:
- DSP cardiomyopathy affects both ventricles and carries a significant risk of ventricular arrhythmia and heart failure.
- Myocardial injury is associated with worse disease outcomes in DSP cardiomyopathy.
- Current diagnostic and risk stratification methods for DSP cardiomyopathy require refinement, particularly for left-dominant disease.
Aims:
Desmoplakin (DSP) cardiomyopathy is an increasingly recognized form of arrhythmogenic cardiomyopathy. With a genotype-specific approach, we characterized the diagnosis, natural history, and risk for ventricular arrhythmia and heart failure in DSP cardiomyopathy.
Methods And Results:
We followed 91 individuals [45 probands, 34% male, median age 27.5 years (interquartile interval 20.0-43.9)] with pathogenic or likely pathogenic DSP variants for a median of 4.3 years. Regarding the ventricular involvement, left predominance was most common (n = 22, 28%) followed by bi-ventricular in 12 (15%) and right predominance in 5 (6%). Myocardial injury (chest pain, elevated troponin, normal coronary angiogram) occurred in 20 (22%) individuals. Incidence rates of sustained ventricular arrhythmia and heart failure (ventricular dysfunction ± symptoms) were 5.9 [95% confidence interval (CI): 3.9-9.1] and 6.7 (95% CI: 4.5-9.8) per 100 person-years, respectively. In univariate regression, myocardial injury was associated with sustained ventricular arrhythmia [hazard ratio (HR) 2.53, 95% CI: 1.05-6.11] and heart failure (HR 7.53, 95% CI: 3.10-18.26). After adjustment, left ventricular ejection fraction <35% and right ventricular dysfunction were prognostic for sustained ventricular arrhythmia while proband status and myocardial injury were prognostic for heart failure (all P < 0.05). The sensitivity of the arrhythmogenic right ventricular cardiomyopathy Task Force Criteria in diagnosing left dominant disease was 0.73; 5/22 (23%) of patients with sustained ventricular arrhythmias did not meet these criteria.
Conclusion:
DSP cardiomyopathy affects both ventricles and carries high risk for ventricular arrhythmia and heart failure. Myocardial injury is associated with worse disease outcomes. Both diagnosis and risk stratification of DSP cardiomyopathy need refinement.
More Related Videos
08:37Sarcomere Shortening of Pluripotent Stem Cell-Derived Cardiomyocytes using Fluorescent-Tagged Sarcomere Proteins.
Published on: March 3, 2021
09:16Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients
Published on: February 28, 2018
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Desmosomes
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cytoskeletal Linker Proteins - Plakins